针对急性髓性白血病的异构移植的近期进展
Juan Montoro1,2, Aitana Balaguer-Roselló1,3, Jaime Sanz1,3,4
1Hematology Department, Hospital Universitario y Politécnico La Fe.
Current opinion in oncology
|October 11, 2023
概括
针对急性骨髓性白血病 (AML) 的全源造血干细胞移植 (allo-HSCT) 已取得进展,减少了毒性和移植对宿主疾病 (GVHD). 进一步的研究旨在改善复发预防和移植结果.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 移植医学 移植医学
背景情况:
- 急性髓性白血病 (AML) 是一种严重的血液性恶性瘤.
- 全源性造血干细胞移植 (allo-HSCT) 是高风险AML的关键治疗方式.
- 移植技术和支持性护理的进步改善了患者的治疗结果.
研究的目的:
- 审查AML的allo-HSCT近期的进展.
- 突出程序和患者管理方面的改进.
- 讨论减少毒性和预防复发的策略.
主要方法:
- 关于用于AML的allo-HSCT最近文献的综述.
- 分析GVHD预防,调节方案和支持性护理方面的进展.
- 对预防复发的新兴策略的评估,包括MRD监测.
主要成果:
- 移植后引入循环胺减少了移植对宿主病 (GVHD) 的发生,并改善了供体的可用性.
- 调节方案和支持性护理的进步降低了整体过程毒性.
- 复发仍然是移植失败的主要原因,需要进一步研究预防策略.
结论:
- 艾洛-HSCT是高风险AML的护理标准.
- 改善接入,降低毒性和更好的复发管理正在改善患者的治疗结果.
- 进一步的研究对于优化最小残留疾病 (MRD) 监测,调节方案和复发预防疗法至关重要.
相关概念视频
01:22Bone Marrow Sampling and Transplants
342
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
342
01:15Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K